Report Detail
Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Technologies
In the United States (U.S.), cardiovascular disease afflicts more than a quarter of the population, causes more than 5 million hospitalizations, and claims nearly 1 million lives each year; additionally, more than $300 billion in direct or indirect healthcare expenditures are incurred annually. A major portion of these expenditures is associated with the management of the most prevalent acute and chronic myocardial conditions such as debilitating drug-refractory angina pectoris, heart failure, ischemic heart disease, and myocardial infarction.